Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122587 · ClinicalTrials.gov registry record · NA
Non-Invasive Brain Stimulation and Substance Use
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT03122587 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 38 participants.
The verdict
NCT03122587, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The will investigate the feasibility and effectiveness and initial efficacy of non-invasive transcranial alternating current stimulation (tACS) on distress tolerance and inhibitory control among treatment seeking substance users.
Interventions
- DEVICE Transcranial Alternating Current Stimulation at 10 Hz
- DEVICE Transcranial Alternating Current Stimulation at 40 Hz
- DEVICE Active sham transcranial alternating current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2017-05-15 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03122587
The ClinicalTrials.gov registry entry for NCT03122587 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transcranial Alternating Current Stimulation at 10 Hz is the first listed.
NCT03122587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03122587 about?
NCT03122587 is a clinical study titled "Non-Invasive Brain Stimulation and Substance Use". The will investigate the feasibility and effectiveness and initial efficacy of non-invasive transcranial alternating current stimulation (tACS) on distress tolerance and inhibitory control among treatment seeking substance users.
What is the current status of trial NCT03122587?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2017-05-15. Estimated completion is 2019-02-01.
What interventions are being tested in trial NCT03122587?
The interventions under investigation include: Transcranial Alternating Current Stimulation at 10 Hz (DEVICE), Transcranial Alternating Current Stimulation at 40 Hz (DEVICE), Active sham transcranial alternating current stimulation (DEVICE).
Who is sponsoring clinical trial NCT03122587?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.